SpectraCure AB

medical devices

About

SpectraCure AB is a Swedish biotechnology and medical technology company based in Lund, focused on innovative cancer treatment solutions, particularly for localized prostate cancer. The company develops advanced photodynamic therapy (PDT) systems that utilize light-sensitive drugs activated by laser light to target and destroy cancer cells while preserving healthy tissue. The flagship product, the Q-PRO® treatment system, offers a precise and minimally invasive therapy tailored for patients with localized prostate cancer. SpectraCure also features the IDOSE platform, which enables real-time laser light dose management during PDT, enhancing treatment accuracy and safety. The company is engaged in multicenter clinical trials across North America and Europe, aiming to advance its therapies for recurrent and primary localized prostate cancer. With a dedicated team led by CEO Dr. Masoud Khayyami, SpectraCure is committed to improving patient outcomes by reducing side effects associated with traditional cancer treatments. The company envisions becoming a leader in focal cancer treatment, enhancing quality of life through personalized PDT solutions.

Technologies

Outlook Microsoft Office 365

Keywords

medical equipment manufacturing precisionsmedicin biotechnology cancerforskning ljusknsligt lkemedel behandlingsprecision behandlingsoptimering individualiserad cancerterapi medicinteknik laserljusdosen styrning solid tumör idose medical equipment and supplies manufacturing medicintekniska system medical research medical device laserbehandling b2b prostatacancer medical technology dosplanering fokal behandling healthcare technology individualiserad behandling cancer i bukspottkörtel laserenhet pdt systemutveckling dosplaneringsplattform fokuserad pdt

Location

1 Gasverksgatan, Lund, Skane County, Sweden, 222 29

Related Companies

Companies in the same industry